Illumina Sales Miss Expectations |  |
|
Posted by Mary Canady July 1st, 2009 .
| |
| No Comments |
San Diego-based Illumina, the maker of genetic analysis tools for biologists, said today that its second-quarter sales fell short of the company’s forecast. Illumina (NASDAQ: ILMN), in a...
[[Click headline to continue reading.]]
[[Click headline to continue reading.]]
See other entries categorized in News, Syndication, Xconomy.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
